Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality (Q37870823)

24 August 2017

1 reference

title

Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality (English)

1 reference

24 August 2017

0 references

1 reference

T Welte

1

1 reference

PubMed ID

21533875

24 August 2017

language of work or name

1 reference

1 May 2011

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

24 August 2017

1 reference

24 August 2017

31

1 reference

24 August 2017

1

1 reference

24 August 2017

33-47

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-011-1272-4

24 August 2017

0 references

cites work

The cost of treating community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Approaches to estimate the population-based incidence of community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Trends in infectious diseases mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

What is new in the treatment of community-acquired pneumonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Pneumonia: still the old man's friend?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

The burden of community-acquired pneumonia in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Managing community-acquired pneumonia: a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Risk factors for community acquired pneumonia (CAP). A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Racial variations in processes of care for patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Optimal treatment strategies for community-acquired pneumonia: high-risk patients (geriatric and with comorbidity).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Hospitalization for pneumonia in the Cardiovascular Health Study: incidence, mortality, and influence on longer-term survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Risk factors for community-acquired pneumonia in adults: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

New evidence of risk factors for community-acquired pneumonia: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Severe community-acquired pneumonia. Risk factors and follow-up epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

High alcohol intake as a risk and prognostic factor for community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Proportion of community-acquired pneumonia cases attributable to tobacco smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Validation of predictive rules and indices of severity for community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Development and validation of a clinical prediction rule for severe community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

A predictive model for the management of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Factors of importance for the long term prognosis after hospital treated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Prior statin use is associated with improved outcomes in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Assessment of illness severity in community acquired pneumonia: a useful new prediction tool?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Validation of a predictive rule for the management of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

CRB-65 predicts death from community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Guidelines for the management of community-acquired pneumonia. Current recommendations and antibiotic selection issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Drug-resistant Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Predicting antimicrobial resistance in invasive pneumococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Staphylococcus aureus pneumonia: emergence of MRSA in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of "mayhem in the lung".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Fatal necrotizing pneumonia due to a Panton-Valentine leukocidin positive community-associated methicillin-sensitive Staphylococcus aureus and Influenza co-infection: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Fatal cases of Staphylococcus aureus pleural empyema in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Pseudomonas aeruginosa pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

A hospital study of community acquired pneumonia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Aetiology and outcome of severe community-acquired pneumonia in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Community-acquired legionella pneumonia in elderly patients: characteristics and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Guidelines for the management of adult lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Type 2 Diabetes and Pneumonia Outcomes: A population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Factores pronósticos de la neumonía adquirida en la comunidad en ancianos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Factors Predicting Mortality in Necrotizing Community-Acquired Pneumonia Caused by Staphylococcus aureus Containing Panton-Valentine Leukocidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1272-4

Sporadic and epidemic community legionellosis: two faces of the same illness

21 January 2018

1 reference

12 December 2020

Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia

1 reference

12 December 2020

Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study

1 reference

12 December 2020

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

12 December 2020

Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study

1 reference

12 December 2020

Gender and sex hormones influence the response to trauma and sepsis: potential therapeutic approaches

1 reference

12 December 2020

A prospective hospital study of the aetiology of community-acquired pneumonia

1 reference

12 December 2020

Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia

1 reference

12 December 2020

Risk factors for community-acquired pneumonia in German adults: the impact of children in the household

1 reference

12 December 2020

CRB-65 for the assessment of pneumonia severity: who could ask for more?

1 reference

12 December 2020

The risk factors for mortality of community-acquired pneumonia in Japan

1 reference

12 December 2020

Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus

1 reference

12 December 2020

Risk and protective factors related to mortality from pneumonia among middleaged and elderly community residents: the JACC Study

1 reference

12 December 2020

Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia

1 reference

12 December 2020

[Pneumonia: state-of-art and perspectives].

1 reference

12 December 2020

Comorbid disease and the effect of race and ethnicity on in-hospital mortality from aspiration pneumonia

1 reference

12 December 2020

Trends in infectious diseases mortality in the United States.

1 reference

12 December 2020

[Prognostic factors and outcome of community-acquired pneumonia in hospitalized adult patients].

1 reference

12 December 2020

Community-acquired pneumonia--factors influencing intensive care admission

1 reference

12 December 2020

[Pneumonia due to Legionella pneumophila. Experience gathered in a University Hospital in Buenos Aires]

1 reference

12 December 2020

Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis

1 reference

12 December 2020

Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores

1 reference

12 December 2020

Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service

1 reference

12 December 2020

Prognosis in community-acquired pneumonia requiring treatment in hospital. Importance of predisposing and complicating factors, and of diagnostic procedures

1 reference

12 December 2020

Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group

1 reference

12 December 2020

Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia

1 reference

12 December 2020

Gender differences in sepsis: genetically determined?

1 reference

12 December 2020

Community-acquired pneumonia and influenza hospitalisations in northern Portugal, 2000-2005.

1 reference

12 December 2020

Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Community-acquired pneumonia in patients requiring hospitalization

1 reference

12 December 2020

COPD is associated with increased mortality in patients with community-acquired pneumonia

1 reference

12 December 2020

Community-acquired pneumonia in elderly patients

1 reference

12 December 2020

Community-associated methicillin-resistant Staphylococcus aureus: review of an emerging public health concern

1 reference

12 December 2020

Health Care–Associated Pneumonia Requiring Hospital Admission

1 reference

12 December 2020

Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia

1 reference

12 December 2020

Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia

1 reference

12 December 2020

The clinical features of severe community-acquired pneumonia presenting as septic shock. Norasept II Study Investigators

1 reference

12 December 2020

[The risk factors of death in community-acquired pneumonia]

1 reference

12 December 2020

Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia

1 reference

12 December 2020

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

12 December 2020

[Risk factors for pneumonia in patients with cardiovascular diseases]

1 reference

12 December 2020

Markers of treatment failure in hospitalised community acquired pneumonia

1 reference

12 December 2020

Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia

1 reference

12 December 2020

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

12 December 2020

Does smoking contribute to community acquired pneumonia?

1 reference

12 December 2020

[Treatment of community acquired pneumonia]

1 reference

12 December 2020

10.1007/S10096-011-1272-4

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21533875